Growth Metrics

Quest Diagnostics (DGX) Equity Income: 2009-2025

Historic Equity Income for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $8.0 million.

  • Quest Diagnostics' Equity Income rose 33.33% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.0 million, marking a year-over-year increase of 42.86%. This contributed to the annual value of $19.0 million for FY2024, which is 26.92% down from last year.
  • Latest data reveals that Quest Diagnostics reported Equity Income of $8.0 million as of Q3 2025, which was down 11.11% from $9.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Equity Income registered a high of $31.0 million during Q1 2022, and its lowest value of $3.0 million during Q4 2022.
  • Its 3-year average for Equity Income is $8.0 million, with a median of $7.5 million in 2023.
  • Per our database at Business Quant, Quest Diagnostics' Equity Income crashed by 88.00% in 2022 and then soared by 166.67% in 2023.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Equity Income stood at $25.0 million in 2021, then crashed by 88.00% to $3.0 million in 2022, then skyrocketed by 166.67% to $8.0 million in 2023, then crashed by 37.50% to $5.0 million in 2024, then surged by 33.33% to $8.0 million in 2025.
  • Its last three reported values are $8.0 million in Q3 2025, $9.0 million for Q2 2025, and $18.0 million during Q1 2025.